Gene therapy strategies in neurodegenerative diseases

Histology and Histopathology

Volumn 16, Issue 3, 2001, Pages 883-893

  Gimenez y Ribotta M ^a  

^a INSERM   (France)

Author keywords

Adenoviruses; Alzheimer's disease; Gene therapy; Motoneurons; Neurodegenerative diseases; Parkinson's disease; Retroviruses

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOTECHNOLOGY; BLOOD BRAIN BARRIER; BRAIN DEGENERATION; CENTRAL NERVOUS SYSTEM; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; HEARING DISORDER; HUNTINGTON CHOREA; MOLECULAR BIOLOGY; MOLECULE; MOTONEURON; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; RETINA DISEASE; RETROVIRUS; REVIEW;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DEAFNESS; GENE THERAPY; GENETIC VECTORS; HUMANS; HUNTINGTON DISEASE; NEURODEGENERATIVE DISEASES; NEURONS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PROMOTER REGIONS (GENETICS); RETINITIS PIGMENTOSA;

ADENOVIRIDAE; ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0034927283     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
2. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats
3. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic genes confers neuroprotection that exceeds the transduced population
4. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer
5. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy
6. Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse
7. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioural impairment in a rat model of Parkinson disease
8. GFAP promoter directs astrocyte-specific expression in transgenic mice
9. Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: Effect on basal forebrain cholinergic neurons during aging
10. Gene therapy strategies for intracranial tumours: Glioma and pituitary adenomas
11. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse
12. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations
13. Somatic gene transfer of NGF to the aged brain: Behavioural and morphological amelioration
14. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor
15. The synucleins: A family of proteins involved in synaptic function, plasticity, neurogeneration and disease
16. Synucleins in synaptic plasticity and neurodegenerative disorders
17. Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioural recovery in experimental Parkinsonism
18. Intracerebral tetracycline-dependent regulation of gene expression in grafts of neural precursors
19. A single adenovirus vector mediates doxycycline-controlled expression of human neural progenitors
20. Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse
21. Recombinant adenovirus: A gene transfer vector for study and treatment of CNS diseases
22. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells
23. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase
24. In vivo expression of therapeutic human genes for dopamine production in the caudades of MPTP-treated monkeys using an AAV vector
25. Experimental models of amyotrophic lateral sclerosis
26. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease
27. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3
28. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases
29. Engineered cells; a promising therapeutic approach for neural disease
30. In vivo and ex vivo gene transfer to the brain
31. The role of neurotrophic factors in regulating the development of inner ear innervation
32. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
33. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: Model for treatment of neuron loss following cochlear degeneration
34. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses
35. Prevention of motoneuron death by adenovirus-mediated neurotrophic factors
36. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
37. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons
38. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
39. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors
40. Antisense gene therapy for neurodegenerative disease?
41. Tetracycline-regulated transgene expression in hippocampal neurones following transfection with adenoviral vectors
42. Genetic classification of primary neurodegenerative disease
43. Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transection
44. Exogeneous expression of L-dopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: Grafting in an animal model of Parkinson's disease
45. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease
46. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration
47. The principles of gene therapy for the nervous system
48. Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain
49. In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells
50. Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible?
51. Bcl-2 prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
52. Adenovirus and adenoassociated virus mediated gene transfer
53. Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: An in vivo model system for the inhibition of neuronal apoptotic cell death
54. Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: Application to the rescue of photoreceptor degeneration
55. Green fluorescent protein as a reporter for gene transfer studies in the cochlea
56. Gene therapy using herpes simplex virus-based vectors
57. An adenovirus vector for gene transfer into neurons and glia in the brain
58. Transgenic models of neurodegenerative diseases
59. Adenovirus insertion encoding the lacZ gene in human nervous cells in primary dissociated cultures
60. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease
61. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa
62. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro and in vivo effects in the rat Parkinson model
63. Long-term functional recovery from age-induced spatial memory impairements by nerve growth factor gene transfer to the rat basal forebrain
64. In vivo gene delivery an stable transduction of nondividing cells by a lentiviral vector
65. Adenovirus vectors enter the brain
66. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse
67. Animal models of human retinal dystrophies
68. Motor neurons disease and animal models
69. Genetic neurodegenerative diseases: The human illness and transgenic models
70. Recent advances in understanding the pathogenesis of Huntington's disease
71. Gene therapy in the central nervous system: Direct versus indirect gene delivery
72. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes
73. Adenovirus for neurodegenerative diseases: In vivo strategies and ex vivo gene therapy using human neural progenitors
74. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
75. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice
76. Transgenic murine cortical neurons expressing human bcl-2 exhibit increased resistance to amyloid beta-peptide neurotoxicity
77. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism
78. Neural transplantation: Problems and prospects for therapeutic applications
79. Viral vectors for modulating gene expression in neurons
80. Age-associated neuronal atrophy occurs in the primarte brain and is reversible by growth factor gene therapy
81. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss
82. Gene therapy: A hard graft for neuroscientists?
83. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer
84. Cell vehicles for gene transfer to the brain
85. Aggregates in neurodegenerative disease: Crowds and power?
86. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine
87. Gene therapy in the adult primate brain intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration
88. Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition
89. Intravenous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats
90. Vecteurs synthétiques pour le transfer de gènes: État actuel et perspectives
91. Induction of midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes
92. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbriafornix transection
93. CNTF overexpression hastens onset of symptoms in motor neuron degeneration (mnd) mice
94. The genetic and molecular mechanisms of motor neuron disease
95. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor
96. Advances in adenoviral vectors: From genetic engineering to their biology
97. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease
98. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures
99. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo